159 related articles for article (PubMed ID: 38902822)
1. Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase.
Liu J; Yu Y; Zhao H; Guo L; Yang W; Yan Y; Lv J
Eur J Med Res; 2024 Jun; 29(1):343. PubMed ID: 38902822
[TBL] [Abstract][Full Text] [Related]
2. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
3. East Asia expert opinion on treatment initiation for chronic hepatitis B.
Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF
Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Huang DQ; Tran A; Yeh ML; Yasuda S; Tsai PC; Huang CF; Dai CY; Ogawa E; Ishigami M; Ito T; Kozuka R; Enomoto M; Suzuki T; Yoshimaru Y; Preda CM; Marin RI; Sandra I; Tran S; Quek SXZ; Khine HHTW; Itokawa N; Atsukawa M; Uojima H; Watanabe T; Takahashi H; Inoue K; Maeda M; Hoang JK; Trinh L; Barnett S; Cheung R; Lim SG; Trinh HN; Chuang WL; Tanaka Y; Toyoda H; Yu ML; Nguyen MH
Hepatology; 2023 Nov; 78(5):1558-1568. PubMed ID: 37184202
[TBL] [Abstract][Full Text] [Related]
5. Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase.
Huang DQ; Li X; Le MH; Le AK; Yeo YH; Trinh HN; Zhang J; Li J; Wong C; Wong C; Cheung RC; Yang HI; Nguyen MH
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1803-1812.e5. PubMed ID: 33465482
[TBL] [Abstract][Full Text] [Related]
6. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
[TBL] [Abstract][Full Text] [Related]
8. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
Cho JY; Paik YH; Sohn W; Cho HC; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Gut; 2014 Dec; 63(12):1943-50. PubMed ID: 24615378
[TBL] [Abstract][Full Text] [Related]
9. Reasons to consider early treatment in chronic hepatitis B patients.
Koffas A; Petersen J; Kennedy PT
Antiviral Res; 2020 May; 177():104783. PubMed ID: 32217150
[TBL] [Abstract][Full Text] [Related]
10. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
[TBL] [Abstract][Full Text] [Related]
11. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
[TBL] [Abstract][Full Text] [Related]
12. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Kim GA; Lim YS; Han S; Choi J; Shim JH; Kim KM; Lee HC; Lee YS
Gut; 2018 May; 67(5):945-952. PubMed ID: 29055908
[TBL] [Abstract][Full Text] [Related]
13. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
Iloeje UH; Yang HI; Chen CJ
Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
[TBL] [Abstract][Full Text] [Related]
14. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
;
J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
[TBL] [Abstract][Full Text] [Related]
15. [New progress on diagnosis and treatment for indeterminate-phase chronic hepatitis B virus-infected patients].
Liu JC; Wu C; Li J
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):370-374. PubMed ID: 38733194
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of hepatitis B virus-related hepatocellular carcinoma.
Ishikawa T
World J Gastroenterol; 2010 May; 16(20):2463-7. PubMed ID: 20503445
[TBL] [Abstract][Full Text] [Related]
17. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
18. Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.
Kim MN; Hwang SG; Kim BK; Park JY; Kim DY; Han KH; Kim SU; Ahn SH
Gut Liver; 2019 Mar; 13(2):197-205. PubMed ID: 30602075
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
20. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up.
Zhang W; Wang X; Wang Y; Zhao X; Duan W; Wang Q; Wu X; Kong Y; Ma H; You H; Ou X; Jia J
Medicine (Baltimore); 2017 Nov; 96(44):e8454. PubMed ID: 29095292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
